CCL2 and IL18 expressions may associate with the anti-proliferative effect of noncontact electro capacitive cancer therapy in vivo [version 2; peer review: 1 approved, 2 approved with reservations]

Background: Noncontact Electro Capacitive Cancer Therapy (ECCT) is a novel treatment modality in cancer. Chemokine (C-C motif) ligand 2 (CCL2) has a major role in the outgrowth of metastatic breast cancer. Interleukin 18 (IL18) plays a role in macrophage alteration, which leads to excessive angiogen...

詳細記述

書誌詳細

主要な著者:	Rarastoeti Pratiwi, Nyoman Yudi Antara, Lalu Gunawan Fadliansyah, Syamsul Arif Ardiansyah, Luthfi Nurhidayat, Eti Nurwening Sholikhah, Sunarti Sunarti, Sitarina Widyarini, Ahmad Ghitha Fadhlurrahman, Hindana Fatmasari, Woro Anindito Sri Tunjung, Sofia Mubarika Haryana, Firman Alamsyah, Warsito Purwo Taruno
フォーマット:	Artigo
言語:	Inglês
出版事項:	F1000 Research Ltd 2020-07-01
シリーズ:	F1000Research
オンライン･アクセス:	https://f1000research.com/articles/8-1770/v2
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!